Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03876847 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Genetics of Spontaneous Coronary Artery Dissection (SCAD-INSPIRE Genetics)

Study acronym: SCAD-INSPIRE
StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. 2 versions Re-verified since May 23, 2024, no change to tracked fieldsv4-v5
  2. Primary and study completion dates: Jan 2022 to Dec 31, 2036v3
  3. Primary and study completion dates: Jan 2021 to Jan 2022v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Spontaneous coronary artery dissection (SCAD) is a rare cause of coronary ischemia and infarction where a tear in blood vessel wall either restricts the flow of blood or the blood becomes trapped in between the layers of the vessel causing the vessel to impinge on the lumen and causing an obstruction or restriction of blood flow. The ultimate goal of this proposal is to further understand the risk factors leading to SCAD with a focus on familial and genetic causes of SCAD.
Trial Details
NCT Number NCT03876847
Lead Sponsor Intermountain Health Care, Inc.
Conditions
(from sponsor)		 Spontaneous Coronary Artery Dissection
Related terms Coronary Artery Dissection, Spontaneous
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov